Christopher Case, MD
Endocrinology, Diabetes & Metabolism · Jefferson City, MONPI 1871552794
Payments from drug & device makers
Across 1,118 payments — averaging $619.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$375K
- Novo Nordisk AS$142K
- Novo Nordisk$99K
- Bayer$55K
- Amarin Pharma, Inc.$14K
- Johnson & Johnson$5K
- plus $2K from 29 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 26 | $374,693 |
| Novo Nordisk AS | 702 | $142,487 |
| Novo Nordisk | 194 | $98,872 |
| Bayer | 45 | $55,103 |
| Amarin Pharma, Inc. | 10 | $14,150 |
| Johnson & Johnson | 11 | $4,866 |
| Corcept Therapeutics | 24 | $285 |
| Dexcom, Inc. | 23 | $281 |
| Amgen(2 entities) | 13 | $223 |
| Sanofi-aventis U.S. LLC | 5 | $162 |
| Abbott | 6 | $151 |
| Novartis | 6 | $123 |
| Lilly USA, LLC | 8 | $119 |
| Xeris Pharmaceuticals, Inc. | 6 | $110 |
| Radius Health, Inc. | 6 | $103 |
| Medtronic(2 entities) | 4 | $63 |
| IBSA Pharma Inc. | 2 | $50 |
| Esperion Therapeutics, Inc. | 3 | $44 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $43 |
| Tolmar, Inc. | 2 | $35 |
| Antares Pharma, Inc. | 2 | $31 |
| Boehringer Ingelheim | 2 | $31 |
| Pfizer | 1 | $29 |
| Insulet Corporation | 2 | $29 |
| AstraZeneca | 2 | $26 |
| Clarus Therapeutics Inc. | 1 | $25 |
| Averitas Pharma Inc. | 1 | $21 |
| Aytu Biopharma, Inc. | 1 | $21 |
| Lifescan, Inc. | 1 | $17 |
| Regeneron Healthcare Solutions, Inc. | 1 | $16 |
| Mannkind Corporation | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
| Merck | 1 | $12 |
| Currax Pharmaceuticals LLC | 1 | $12 |
| Tandem Diabetes Care, Inc. | 1 | $11 |
How this compares
$692,270 in reported general payments places this provider in the 95th percentile of 182 endocrinology, diabetes & metabolism providers in Missouri.
See all endocrinology, diabetes & metabolism providers in Missouri →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other endocrinology, diabetes & metabolism in Jefferson City
- Alan RaubaJefferson City$594K
- Ralph DudaSpringfield$3M
- Thomas NickolasSaint Louis$945K
- Anne GoldbergSaint Louis$830K
- Janet McGillSaint Louis$828K
- Gregory LedgerSpringfield$690K
- Karen Chang-ChenChesterfield$640K
- Julie SilversteinSaint Louis$536K
- Ralph OiknineChesterfield$414K
- Mariana TouzaNorth Kansas City$384K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.